Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Coursera Shares Face Investor Skepticism Despite Quarterly Beat

Andreas Sommer by Andreas Sommer
November 1, 2025
in Analysis, Earnings, Nasdaq, Tech & Software
0
Coursera Stock
0
SHARES
13
VIEWS
Share on FacebookShare on Twitter

Coursera finds itself at a critical juncture as market analysts maintain a cautious stance on the educational technology firm. The investment community has settled on a consensus “Hold” recommendation, with thirteen research firms providing mixed assessments. Their collective outlook includes six “Buy” ratings balanced against six “Hold” recommendations and one “Sell” position, establishing an average price target of $12.36 per share.

Profitability Concerns Overshadow Quarterly Performance

The company’s third-quarter results demonstrated operational strength, yet failed to convince skeptics. Coursera posted adjusted earnings of $0.10 per share, exceeding the $0.09 projection from market watchers. Revenue growth remained healthy at 10.3%, pushing total sales to $194.20 million and surpassing expectations.

In response to these solid figures, management upgraded its full-year guidance. The revised forecast now anticipates 2025 revenue between $750 million and $754 million, representing a $10 million increase from previous expectations.

Analytical Divide Highlights Uncertainty

Financial institutions remain divided in their assessment despite the positive earnings surprise. Needham & Company stands firmly in the bullish camp, reiterating its “Buy” rating with a $14.00 price objective. Morgan Stanley adopted a more measured position, raising its target to $12.00 while maintaining an “Equal Weight” designation.

Should investors sell immediately? Or is it worth buying Coursera?

Bank of America shifted its perspective upward, moving from “Underperform” to “Neutral” with a $12.00 valuation. UBS followed a similar pattern, increasing its price target from $10.00 to $11.00 while keeping its “Neutral” stance. In a contrasting move, Zacks Research downgraded Coursera from “Strong Buy” to “Hold,” reflecting growing caution.

Financial Health Indicators Raise Red Flags

The core challenge for Coursera remains its inability to translate top-line growth into bottom-line results. The quarter concluded with an $8.6 million net loss, producing a negative net margin of 6.19%. Shareholder returns also suffered, with return on equity standing at -4.80%.

Further examination reveals persistent operational inefficiencies. The EBIT margin for the trailing twelve months registered at -6.9%, while the profit margin reached -7.05%. These figures indicate ongoing cost management struggles despite the company maintaining a respectable gross margin of 54.4%.

As Coursera looks toward the final quarter, management projects revenue between $189 million and $193 million. With the analytical community predominantly recommending holding positions and profitability concerns remaining unresolved, investor sentiment toward the education technology platform continues to reflect significant uncertainty.

Ad

Coursera Stock: Buy or Sell?! New Coursera Analysis from February 7 delivers the answer:

The latest Coursera figures speak for themselves: Urgent action needed for Coursera investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Coursera: Buy or sell? Read more here...

Tags: Coursera
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock
Analysis

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock
Analysis

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026
Next Post
Richardson Electronics Stock

Richardson Electronics Shares Surge on Stellar Quarterly Performance

Mosaic Stock

Mosaic Shares Under Pressure Ahead of Q3 Earnings Release

Entravision Communications Stock

Entravision Communications: A Stock at a Critical Juncture

Recommended

Anticipating Navigator Holdings Quarterly Earnings Report Analysts Predict 030 EPS

2 years ago
Sandy Spring Stock

Sandy Spring Bancorp’s Final Chapter: A New Era Under Atlantic Union

3 months ago
Certara Stock

Certara Stock: Regulatory Milestone and Strong Fundamentals Fuel Recovery Hopes

6 months ago
Meta Stock

Meta Faces Mounting Pressure from Regulators and Strategic Shifts

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Navigating Change: Schnitzer Steel’s Digital and Structural Evolution

Akso Health Group Pivots to Oncology with Global Patient Initiative

Trending

Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

by Kennethcix
February 6, 2026
0

Deluxe Corporation is successfully shedding its legacy identity as a check-printing specialist. The company's strategic pivot toward...

Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026
Vir Biotechnology Stock

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

February 6, 2026
Tellurian Stock

Tellurian Acquisition Finalized as Woodside Takes Control

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Deluxe Stock Gains Momentum on Successful Fintech Transition
  • Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches
  • Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com